Annexin V-FITC/PI Apoptosis Kit
中文名称：Annexin V-FITC / PI细胞凋亡检测试剂盒
Price:
- 应用： 细胞凋亡-Annexin V
| 检测原理 | Annexin V是一种钙离子依赖性磷脂结合蛋白，与磷脂酰丝氨酸PS有高度亲和力，可通过细胞外侧暴露的PS与凋亡早期细胞胞膜结合，将Annexin V标记荧光染料，利用流式细胞仪检测细胞凋亡。
细胞核染料（PI,DAPI,7-AAD）可与双链DNA特异性结合，并产生强烈的荧光，正常情况下无法透过细胞膜。由于凋亡晚期或坏死细胞膜丧失完整性，细胞核染料（DAPI、PI、7-AAD）可进入细胞内对DNA进行染色，与Annexin V搭配使用，可区分处于不同凋亡时期的细胞。 |
| 检测方法 | 荧光法;流式 |
| 样本类型 | 细胞 |
| 检测时间 | 40 min |
| 检测仪器 | 流式细胞仪 |
| 荧光 | FITC |
| Ex/Em | 490/530 |
| Channel set | FITC |
| 自备试剂 | PBS(E-BC-R187), 去离子水 |
| 保存温度 | 该产品可在 2~8°C避光条件下保存12个月。 |
| 有效期 | 12个月 |
| 运输条件 | 冰袋 |
-
N6-methyladenosine-modified SENP1, identified by IGF2BP3, is a novel molecular marker in acute myeloid leukemia and aggravates progression by activating AKT signal via de-SUMOylating HDAC2
IF: 27.700Journal： Molecular Cancer (2024) -
Anti irradiation nanoparticles shelter immune organ from radio-damage via preventing the IKK/IκB/NF-κB activation
IF: 27.700Journal： Molecular Cancer (2024) -
Tumor-Specific Protein Induced in Situ Self-Assembly of Peptide Drugs for Synergistic Mitochondria Disruption
IF: 27.400Journal： ADVANCED MATERIALS (2024) -
Tumor-derived apoptotic extracellular vesicle-mediated intercellular communication promotes metastasis and stemness of lung adenocarcinoma
IF: 18.900 -
Reversing EZH2-Mediated Epigenetic Silence with Photodynamic Polymeric Nanoparticles for Synergistically Enhanced Antitumor Immunotherapy
IF: 18.500Journal： ADVANCED FUNCTIONAL MATERIALS (2024) -
Dual-layer microneedles with NO/O2 releasing for diabetic wound healing via neurogenesis, angiogenesis, and immune modulation
IF: 18.000Journal： Bioactive Materials (2024) -
Endowing Pt(IV) with Perfluorocarbon Chains and Human Serum Albumin Encapsulation for Highly Effective Antitumor Chemoimmunotherapy
IF: 15.800Journal： ACS Nano (2024) -
Extracellular vesicle-packaged lncRNA from cancer-associated fibroblasts promotes immune evasion by downregulating HLA-A in pancreatic cancer
IF: 15.500Journal： Journal of Extracellular Vesicles (2024) -
A Novel Drug Candidate for Sepsis Targeting Heparanase by Inhibiting Cytokine Storm
IF: 14.300Journal： Advanced Science (2024) -
A Spatiotemporally Controlled Gene-Regulation Strategy for Combined Tumor Therapy Based on Upconversion Hybrid Nanosystem
IF: 14.300Journal： Advanced Science (2024)
| E-CK-A111 | Annexin V-FITC Reagent | 500Tests , 200 Tests , 100 Tests , 50 Tests |
| E-CK-A151 | Annexin V Binding Buffer (10×) | 50mL , 10mL |
| E-CK-A212 | Annexin V-FITC/7-AAD Apoptosis Kit | 200Assays , 100Assays , 50Assays , 20Assays |
| E-CK-A252 | Annexin V-FITC/DAPI Apoptosis Kit | 200Assays , 100Assays , 50Assays , 20Assays |
| E-CK-A301 | Mitochondrial Membrane Potential Assay Kit (with JC-1) | 100Assays , 50Assays , 20Assays |
| E-CK-A320 | One-step TUNEL In Situ Apoptosis Kit (Green, FITC) | 100 Assays , 50 Assays , 20Assays |
